anti-Ig Lambda antibody product blog
Tags: Antibody; Monoclonal Antibody; Ig Lambda Light Chain; anti-Ig Lambda antibody; Ig Lambda;
The Ig Lambda n/a (Catalog #MBS140093) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Ig Lambda Light Chain can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA).By direct ELISA, 1:10,000 dilution will yield 1.0 O.D using alkaline phosphatase conjugated rabbit anti-mouse Ig. Researchers should empirically determine the suitability of the Ig Lambda n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The Ig Lambda n/a product has the following accession number(s) (GI #1165318) (NCBI Accession #AAA85630.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Type: Mouse Anti Human Monoclonal. Reconstitution: Reconstitute with H20 to get a 1 mg/ml concentration. Mix gently, wash the sides of the vial and wait 30-60 seconds before use.
Immunogen: Purified hIgG Lambda.
Physical Appearance: Sterile Filtered White lyophilize (freeze-dried) powder. . In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Ig Lambda are readily searchable from our website. Different antibodies against the same target such as Ig Lambda may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.